CMPX logo

CMPX
Compass Therapeutics Inc

755
Mkt Cap
$931.05M
Volume
3.16M
52W High
$6.88
52W Low
$1.60
PE Ratio
-11.92
CMPX Fundamentals
Price
$5.17
Prev Close
$5.45
Open
$5.45
50D MA
$5.76
Beta
1.58
Avg. Volume
2.12M
EPS (Annual)
-$0.4216
P/B
4.68
Rev/Employee
$0.00
$647.75
Loading...
Loading...
News
all
press releases
Compass Therapeutics (NASDAQ:CMPX) Trading Down 5.4% - Here's Why
Compass Therapeutics (NASDAQ:CMPX) Stock Price Down 5.4% - Should You Sell...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
Traders Buy High Volume of Compass Therapeutics Call Options (NASDAQ:CMPX)
Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) saw unusually large options trading on Tuesday. Stock traders bought 7,069 call options on the stock. This represents an increase of 411% compared to the average daily volume of 1,383 call options...
MarketBeat·11d ago
News Placeholder
Compass Therapeutics (NASDAQ:CMPX) Receives Buy Rating from Guggenheim
Guggenheim restated a "buy" rating and set a $12.00 price target on shares of Compass Therapeutics in a research note on Tuesday...
MarketBeat·18d ago
News Placeholder
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Recommendation of "Moderate Buy" by Brokerages
Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the fifteen brokerages that are covering the firm, MarketBeat.com...
MarketBeat·24d ago
News Placeholder
HC Wainwright Has Positive Estimate for CMPX FY2026 Earnings
Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) - Stock analysts at HC Wainwright lifted their FY2026 earnings estimates for Compass Therapeutics in a report issued on Thursday, March 5th. HC...
MarketBeat·1mo ago
News Placeholder
What is HC Wainwright's Estimate for CMPX Q1 Earnings?
Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Compass Therapeutics in a research report...
MarketBeat·1mo ago
News Placeholder
Compass Therapeutics (NASDAQ:CMPX) Releases Earnings Results, Beats Estimates By $0.01 EPS
Compass Therapeutics (NASDAQ:CMPX - Get Free Report) released its earnings results on Thursday. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat·1mo ago
News Placeholder
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) DelveInsight
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight Biliary Tract Cancer Market is Predicted to Exhibit...
PR Newswire·1mo ago
News Placeholder
Monashee Investment Management LLC Has $4.38 Million Stake in Compass Therapeutics, Inc. $CMPX
Monashee Investment Management LLC grew its position in Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) by 657.6% in the third quarter, according to its most recent Form 13F filing with the...
MarketBeat·1mo ago
News Placeholder
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Moderate Buy" by Analysts
Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the fourteen ratings firms that are currently covering the...
MarketBeat·2mo ago
<
1
2
...
>

Latest CMPX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.